Knight Therapeutics (GUD) Stock Chart & Stock Price History C$5.84 -0.02 (-0.34%) As of 10:57 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock Knight Therapeutics Stock Price Performance The Knight Therapeutics (GUD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 4.10%, with a year-to-date return of 9.36%. In the past month, the stock has decreased 5.50%, reflecting recent market activity. As of the latest close, Knight Therapeutics traded at C$5.86 with a market cap of C$583.97 million and volume of 18,211 shares. Five years ago, the stock traded at C$5.76, representing a 1.39% increase over that period. At the time, it had a market cap of C$754.20 million and a volume of 216,417 shares. Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.04%1 Month Performance-5.50%3 Month Performance-4.42%Year-To-Date Performance+9.36%1 Year Performance+4.10%5 Year Performance+1.39% GUD Stock Chart for Wednesday, October, 22, 2025 GUD Chart by TradingView Knight Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/21/2025C$5.88C$5.86-0.34%C$5.87C$5.8318,211 shsC$583.97 million10/20/2025C$5.78C$5.88+1.73%C$5.88C$5.7519,510 shsC$585.96 million10/17/2025C$5.78C$5.78C$5.78C$5.7333,799 shsC$575.99 million10/16/2025C$5.75C$5.78+0.52%C$5.79C$5.7524,670 shsC$575.99 million10/15/2025C$5.75C$5.75C$5.80C$5.7079,239 shsC$573.01 million10/14/2025C$5.77C$5.75-0.35%C$5.79C$5.6871,975 shsC$573.01 million10/13/2025C$5.77C$5.77C$5.90C$5.7538,920 shsC$575.00 million10/10/2025C$5.89C$5.77-2.04%C$5.90C$5.7538,920 shsC$575.00 million10/09/2025C$5.87C$5.89+0.34%C$5.93C$5.8261,117 shsC$586.96 million10/08/2025C$5.85C$5.87+0.34%C$5.92C$5.8323,183 shsC$584.96 million Get the Latest News and Ratings for GUD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/07/2025C$5.91C$5.85-1.02%C$5.92C$5.8072,500 shsC$582.97 million10/06/2025C$5.85C$5.91+1.03%C$5.93C$5.8544,516 shsC$588.95 million10/03/2025C$5.83C$5.85+0.34%C$5.91C$5.8343,167 shsC$582.97 million10/02/2025C$5.93C$5.83-1.69%C$5.96C$5.8324,902 shsC$580.98 million10/01/2025C$5.88C$5.93+0.85%C$6.01C$5.8138,000 shsC$590.94 million09/30/2025C$5.92C$5.88-0.68%C$5.92C$5.8827,199 shsC$585.96 million09/29/2025C$5.93C$5.92-0.17%C$6.01C$5.8842,210 shsC$589.95 million09/26/2025C$6.08C$5.93-2.47%C$6.08C$5.9346,390 shsC$590.94 million09/25/2025C$6.07C$6.08+0.16%C$6.09C$6.0449,193 shsC$605.89 million09/24/2025C$6.04C$6.07+0.50%C$6.11C$6.0430,462 shsC$604.89 million09/23/2025C$6.18C$6.04-2.27%C$6.17C$6.0342,928 shsC$615.86 million09/22/2025C$6.23C$6.18-0.80%C$6.23C$6.1345,983 shsC$615.86 million Related Companies CRON Stock Price Chart DHT.UN Stock Price Chart WEED Stock Price Chart ACB Stock Price Chart CPH Stock Price Chart OGI Stock Price Chart SUGR Stock Price Chart HLS Stock Price Chart RX Stock Price Chart CRDL Stock Price Chart Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:GUD) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GUD Stock Alerts